Project Grant HT94252510796
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$846K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $218,055.00 to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to conduct research on "ENHANCING EARLY DETECTION OF PANCREATIC CANCER USING GPT-EMBEDDED EHR MODELS: A NOVEL APPROACH FOR IMPROVED PREDICTIVE PERFORMANCE AND INTERPRETABILITY". The award period runs from Aug 1, 2025 to Jul 31,...
This federal Project Grant award of $144,018.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Beckman Research Institute of the City of Hope in conducting a telehealth intervention to impact quality of life and pancreatic cancer survivorship. The award period runs from August 1, 2024 to July 31, 2027. The Project Grant aims to develop and evaluate a telehealth-based intervention to improve outcomes for pancreatic...
The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $1,175,982 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a telehealth intervention aimed at improving quality of life and pancreatic cancer survivorship. The grant, awarded to the Beckman Research Institute of the City of Hope, a nonprofit research organization, will fund the development and implementation of this telehealth program over a 3-year period from August 2024 to July 2027. The project will leverage...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $388,194 to The Johns Hopkins University to conduct research on "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for critical health challenges. The 3-year project, running from...
This federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award has a performance period from July 1, 2025 to June 30, 2028 and aims to transform healthcare for military service members, veterans, and the general public through innovative biomedical...
The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the...
This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The $988,740 award, effective June 15, 2025 through June 14, 2028, will fund research by Weill Medical College of Cornell University to develop "Genomically Informed Morphological Stromal Signatures to Predict Lethal...
This Project Grant award of $610,656.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by The Trustees of Columbia University in the City of New York to decipher epigenetic mechanisms that dictate poor responses to KRAS inhibition in lung cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations in critical health...